Important Information Regarding Vyzulta

Posted in Latest News on March 16, 2018.

During the March 9, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Vyzulta (latanoprostene bunod ophthalmic solution) 0.024%.

Important note, Vyzulta, at this time, cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on this site, and at that time Vyzulta may be prescribed by certified optometrists.

 



More Latest News

Board Chairs/Vice Chairs Annual Long-range Planning Meeting
January 11, 2019

The Annual Long Range Planning meeting has been scheduled for Friday, May 31, 2019. Please click here for more information. Continue reading


Rule 64B13-5.001 Hours Requirement
December 20, 2018

If you are seeking Florida jurisprudence CE credits for attending a disciplinary hearing please see the meeting site information for the upcoming February 8, 2019 board meeting. Continue reading